Senores Pharmaceuticals Limited has informed the Exchange about Transcript of Business Update Call held on December 16, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted the transcript of its business update call conducted on December 16, 2025, to the stock exchange. The filing is a routine compliance disclosure and makes the management's commentary from the call publicly available. Investors can review the transcript for details on the company's recent performance, strategy, and outlook shared during the call. No specific financial figures or forward-looking guidance are included in this filing notice itself.
Neutral in the short term as this is a procedural filing. Investors should read the actual transcript for any management commentary that could influence sentiment or expectations about the company's growth and margins.